One study performed integrated global quantitative tandem-mass-tag (TMT)-based proteomic and phosphoproteomic analyses in MM samples and identified CDK6 upregulation to be a mechanism of IMiD resistance [148]. Here, CDK6 is linked to Miyoshi myopathy.